Document Detail

Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia.
MedLine Citation:
PMID:  11740306     Owner:  NLM     Status:  MEDLINE    
PURPOSE: We have modified for mice the activity wheel model of Routtenberg to study the effects of tyrosine on exercise tolerance, behavior, and brain neurochemistry. METHODS: Mice were fed for 2 h.d(-1) over a 2-wk period. During the second week, each group was injected daily with either saline or tyrosine (100 and exercised on a running wheel. Controls were in cages with inactivated wheels and received the same treatment and feeding protocols as the experimental groups. Food consumption and cognitive function (eight-arm maze) were evaluated for 1 wk. Brains were then assayed for adrenergic and serotonergic metabolites. RESULTS: Activity together with a restricted diet caused extreme weight loss (27%) (P < 0.001) together with decreased food consumption (22%) (P < 0.001). Tyrosine restored food consumption to that of the controls (P < 0.001) with no effect on weight, since there was a 22% increase in activity (P < 0.001). Saline injections caused an 18% decrease in activity (P < 0.001). Both activity and tyrosine improved maze performance (P < 0.05). In the hypothalamus, activity caused a significant increase in 5-hydroxytryptamine (5-HT) (P < 0.001), 5-hydroxyindoleacetic acid (5-HIAA) (P < 0.01), and dopamine (P < 0.05); tyrosine prevented the increase in 5-HT (P < 0.05) and increased 5-HIAA in the controls (P < 0.01). With regard to hippocampal 5-HT, there was a significant increase in 5-HIAA following activity (P < 0.05), whereas tyrosine caused significant increase in 5-HIAA in the controls (P < 0.01). Activity significantly decreased the level of hippocampal 3,4-dihydroxyphenylacetic acid (DOPAC), whereas tyrosine decreased its level only in the controls (both at P < 0.0001). The level of tyrosine hydroxylase increased with activity (P < 0.05), and tyrosine decreased it significantly (P < 0.05). CONCLUSION: Activity anorexia is associated with increased hypothalamic 5-HT concentrations. Tyrosine administration reverses this, and significantly improves food consumption, cognitive behavior, and activity performance. Such nutritional modulations may have implications for the treatment of eating disorders and, in normal circumstances, tyrosine may improve exercise tolerance and delay fatigue.
Y Avraham; S Hao; S Mendelson; E M Berry
Related Documents :
24366016 - Management of sport-related concussion: a review.
17208946 - Peritoneal tissue-oxygen tension during a carbon dioxide pneumoperitoneum in a mouse la...
20045396 - Three weeks voluntary running wheel exercise increases endoplasmic reticulum stress in ...
23923026 - Profiling of circulating micrornas after a bout of acute resistance exercise in humans.
22831916 - Effects of a physical activity behavior change intervention on inflammation and related...
15212756 - Optimizing fat oxidation through exercise and diet.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Medicine and science in sports and exercise     Volume:  33     ISSN:  0195-9131     ISO Abbreviation:  Med Sci Sports Exerc     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2001-12-12     Completed Date:  2002-01-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8005433     Medline TA:  Med Sci Sports Exerc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2104-10     Citation Subset:  IM; S    
Department of Human Nutrition and Metabolism, Hebrew University-Hadassah Medical School, Jerusalem, Israel 91120.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anorexia / etiology,  physiopathology*
Appetite / drug effects*,  physiology
Body Weight
Catecholamines / analysis
Cognition / drug effects*,  physiology
Energy Intake / drug effects
Physical Conditioning, Animal*
Physical Endurance / drug effects*
Serotonin / analysis
Tyrosine / metabolism,  pharmacology*
Tyrosine 3-Monooxygenase / analysis,  drug effects
Reg. No./Substance:
0/Catecholamines; 50-67-9/Serotonin; 55520-40-6/Tyrosine; EC 3-Monooxygenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of visual impairment on stroke parameters in Paralympic swimmers.
Next Document:  Creatine supplementation combined with resistance training in older men.